Quantum-Si (NASDAQ:QSI) Issues Earnings Results, Beats Estimates By $0.06 EPS

Quantum-Si (NASDAQ:QSI) released its quarterly earnings data on Tuesday. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.06, FiscalAI reports. Quantum-Si had a negative return on equity of 47.90% and a negative net margin of 3,677.97%.The business had revenue of $0.45 million for the quarter, compared to analysts’ expectations of $0.76 million.

Quantum-Si Price Performance

Shares of NASDAQ:QSI traded up $0.01 on Tuesday, reaching $0.95. The company’s stock had a trading volume of 2,910,528 shares, compared to its average volume of 4,438,669. Quantum-Si has a 52-week low of $0.89 and a 52-week high of $3.10. The stock’s 50-day moving average is $1.13 and its two-hundred day moving average is $1.38. The stock has a market capitalization of $204.28 million, a P/E ratio of -1.41 and a beta of 2.98.

Analysts Set New Price Targets

A number of brokerages have weighed in on QSI. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a research note on Monday, December 29th. Canaccord Genuity Group reduced their price objective on Quantum-Si from $2.00 to $1.50 and set a “hold” rating for the company in a research report on Monday, December 22nd. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $3.55.

Insiders Place Their Bets

In related news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the firm’s stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $1.28, for a total value of $30,344.96. Following the completion of the sale, the chief executive officer owned 2,578,018 shares in the company, valued at $3,299,863.04. This trade represents a 0.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider John S. Vieceli sold 21,927 shares of the company’s stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $1.28, for a total value of $28,066.56. Following the completion of the sale, the insider owned 800,973 shares in the company, valued at approximately $1,025,245.44. This represents a 2.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 54,261 shares of company stock worth $69,454. 30.04% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Quantum-Si by 0.5% during the third quarter. Vanguard Group Inc. now owns 8,714,507 shares of the company’s stock worth $12,287,000 after acquiring an additional 44,846 shares during the last quarter. Geode Capital Management LLC grew its stake in Quantum-Si by 9.8% during the 4th quarter. Geode Capital Management LLC now owns 4,114,375 shares of the company’s stock valued at $4,527,000 after purchasing an additional 367,206 shares in the last quarter. Millennium Management LLC purchased a new stake in Quantum-Si during the 1st quarter worth approximately $4,721,000. State Street Corp increased its holdings in Quantum-Si by 26.5% during the 4th quarter. State Street Corp now owns 3,562,721 shares of the company’s stock worth $3,919,000 after purchasing an additional 745,231 shares during the last quarter. Finally, Squarepoint Ops LLC acquired a new position in shares of Quantum-Si in the 3rd quarter valued at approximately $865,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.